Doctor: I’ve completed my clinical examination and I’m happy to inform you that you remain stable. Taking into consideration both your laboratory results and the clinical examination where I checked your joints, you are certainly in remission. About a week ago you should have received a letter from our office telling you about a new medication we would like to transition you to. It works in precisely the same way as the medication you are on now and I am confident you will continue to do well on the new medication. Do you have any questions? 

Patient: I received a letter from the department informing me about the transition. This letter explained to me what a biosimilar is and why transitioning to a biosimilar medication is a good idea in my case. You’ve gotten me to where I am today so I trust that everything is going to be absolutely fine with this new medication. What happens if I don’t respond well to the medication?

Doctor: Well that shouldn’t be the case. However, if your disease activity were to flare-up, it would likely be due to a loss of response to either of the medications as they are essentially the same thing. But you should know that we’re here if ever you need any support. You are always welcome to contact me or any of the other team members. Later on, you will be scheduled for some time with a nurse to receive the new medication. Here you will get detailed information about how to take the medication. What we’ve seen from real life data is that both your old medication and the new biosimilar have similar efficacy and safety profiles. So I really do believe that it will be a smooth transition, as it is based on solid evidence. 

Patient: I trust you. Thank you for the explanation.

Doctor: Great. Thank you very much. And remember, I and my team are here to answer any questions you may have.

BIO-BBU-0026j - Date of preparation: April 2018

Doctor: Hello Mr Muller:   I’ve completed my clinical examination and I’m pleased to let you know that everything seems OK. Your laboratory results and the clinical examination where I checked your joints lead me to believe that you are in remission. You seem to be responding to treatment. About a week ago you received a letter from our office telling you about a new medication we would like to transition you to. I understand from the team that you have some concerns and that you’ve done some of your own independent research into the biosimilar medication.

Patient: As I told the team I have some concerns about transitioning from a treatment that is working. You yourself just said that I am in remission. Why would we change anything.

Doctor: I completely understand your concerns and you should feel confident that this biosimilar medication we are recommending works the same as the medication you are currently taking. There is a lot of information that I and my team will make available to you. In addition to that, I can point you to some very credible resources on the internet. Making yourself familiar with the information is important. Please read it. I am confident that you will see that the biosimilar product works the same as the product you are on. You will continue to do well on the new treatment.

Patient: I look forward to recieve the information from you. If I have any questions can I contact you?

Doctor: Yes, of course. Any time.

BIO-BBU-0026k - Date of preparation: April 2018

Doctor: Hello Ms Hansen. We’ve been discussing your clinical joint examination and your lab values, and are considering whether you could be a candidate to transition from your present medication to a biosimilar. I know you have a busy life, juggling your career and your family life, wherefore we  all want to ensure that this transition process runs as smoothly as possible. It’s important for us that you really understand what this is all about – and that you feel well informed and secure throughout the process. It’s also vital that you stick to your appointments, so that we can monitor you and care for you.

Patient: That sounds like a really good idea. What’s most important for me is that it doesn’t interfere with my life. I’m a busy woman and I travel a lot. So for me, I need this transition to run as if nothing  changes with respect  to my life. Basically, I just need to be sure that I can carry on doing what I do now -  just live my normal life.

Doctor: I feel confident that you can do just that. These biosimilars are built based on strong scientific research, and show the same efficacy and safety profile as the originator preparation that you have been taking so far. It's important for me that you come to your appointments as you have done in the past, so we can follow up on everything. Then the entire process will run smoothly.

Patient: That sounds perfect. I expect everything will run just as I am used to when transitioning to the biosimilar. With that, I’ll be just fine.

Doctor: Great. Thank you very much.

BIO-BBU-0026l - Date of preparation: April 2018

Doctor: Hello and welcome Ms. Smith. So we’re here today to switch you over to this cheaper biological preparation. You need to visit the nurse afterwards to receive it, but don’t worry, its business as usual for you. 

Patient: But why do I have to change? I don’t understand. I haven’t heard anything about switching.

Doctor: That’s just a decision that has been made. You shouldn’t think so much about it. So just go down to the nurses to get your new drug and everything will be fine – nothing to worry about. 

Patient: But is it a different drug? What about side effects? I mean, I know nothing about this!

Doctor: Don’t worry about these things. It’s really identical to the other drug you used, so you just go ahead and collect your medication, ok? I’ve a really busy schedule, so the nurses can give you any additional information and then you can go home, ok?

Patient: But what about………I’m a bit confused about all this?

Doctor: You will be fine. Thank you very much, bye bye.

BIO-BBU-0026i - Date of preparation: April 2018